Association of British Clinical Diabetologists

Degludec Nationwide Audit

 
Home Live ABCD audits of new therapies and devices All ABCD nationwide audits Future audits of new therapies ABCD worldwide audits
     

Above - scene from an animation explaining the mode of action of insulin degludec - click to see Powerpoint slide show

 

Above: In clinical trials there was considerably less intra-subject variability with degludec than with glargine. Potentially therefore patients with very variable patterns of home blood glucose monitoring may benefit from a switch to degludec  click to enlarge

 

Above: In clinical trials degludec was associated with less hypoglycaemia than other insulins and allowed for flexible dosing. The audit may give insight into whether these potential advantages translate in real clinical practice - click to enlarge

 

ABCD nationwide insulin degludec audit

About the ABCD nationwide degludec audit
This audit follows on from the success of the ABCD nationwide exenatide, liraglutide, exenatide QW, and dapagliflozin audits. With many older established insulins in common usage, it will be important to try to gain insight into degludec in real clinical practice by attempting to record the routine data on all patients treated with this new insulin, if possible, so that the most accurate picture of it can be obtained. By pooling the data nationally we will all learn more quickly from the shared experience. In clinical trials degludec was associated with less hypoglycaemia than other insulins and allowed for flexible dosing. There was less intra-subject variability than with glargine. Potentially therefore patients with very variable patterns of home blood glucose monitoring, particularly overnight and fasting, may benefit from a switch to insulin degludec. The audit may give insight into whether these potential advantages translate in real clinical practice. The tool will be hosted on a tool very similar to that used in the liraglutide audit and so those taking part in that audit will find it particularly easy. The audit will launch in conjunction with the Autumn ABCD meeting, November, 2014 and has a number of objectives.

Collect data on-line or via paper forms
The degludec on-line audit tool is so easy to use that live data entry in clinic is a real option to be considered. Otherwise to facilitate data collection during clinics there are two paper forms which exactly match the data that can be entered into the audit tool. You can download and print these forms locally or
order pre-printed data entry forms.

To download the forms to printout for use, use the following links:

Download first visit data entry form
Download follow up visit data entry form

Non ABCD members
Non ABCD members are welcome to take part in the audit and will be given access to the on-line audit tool when they register for the audit.

Register to take part in the audit and access to the on-line tool
To register for the audit and be given access to the on-line tool click here.

Further information
Further enquiries may be made to the ABCD nationwide audits database administrator of the project, Jayne Sterratt

   Register for the audit

Access the on-line tool

Degludec audit objectives

Order preprinted data entry forms

Download first visit data entry form

Download follow up visit data entry form

Further information- contact us

Main ABCD homepage

     

The ABCD nationwide insulin degludec audit is an independent audit supported by an unrestricted grant from Novo Nordisk

Working to support high quality diabetes care in the UK